Adaptive Biotechnologies (ADPT) Gross Profit Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 9.56% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.50% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 12.14% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.32% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.47% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 119.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 10.79% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 12.13% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 8.91% |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 47.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.10% |
| Dec 31, 2025 | 81.74% |
| Sep 30, 2025 | 154.69% |
| Jun 30, 2025 | 71.24% |
| Mar 31, 2025 | 48.87% |
| Dec 31, 2024 | 12.40% |
| Sep 30, 2024 | 60.28% |
| Jun 30, 2024 | 333.82% |
| Mar 31, 2024 | 25.60% |
| Dec 31, 2023 | -32.22% |
| Sep 30, 2023 | -43.59% |
| Jun 30, 2023 | -133.54% |
| Mar 31, 2023 | -25.41% |
| Dec 31, 2022 | 63.78% |
| Sep 30, 2022 | 30.24% |
| Jun 30, 2022 | 9.73% |
| Mar 31, 2022 | -10.63% |
| Dec 31, 2021 | -1.62% |
| Sep 30, 2021 | 24.85% |
| Jun 30, 2021 | 72.56% |